Highly specific radiographic marker predates clinical diagnosis in progressive supranuclear palsy

被引:15
|
作者
Owens, Emily [1 ]
Krecke, Karl [2 ]
Ahlskog, J. E. [1 ]
Fealey, Robert [1 ]
Hassan, Anhar [1 ]
Josephs, Keith A. [1 ]
Klassen, Bryan [1 ]
Matsumoto, Joseph [1 ]
Bower, James [1 ]
机构
[1] Mayo Clin, Dept Neurol, 200 Second St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Neuroradiol, 200 Second St SW, Rochester, MN 55905 USA
关键词
Progressive supranuclear palsy; Imaging; MRI; MULTIPLE SYSTEM ATROPHY; PARKINSONS-DISEASE; ROUTINE MRI; PONS RATIO; MIDBRAIN; DIFFERENTIATION; VARIANT; INDEX;
D O I
10.1016/j.parkreldis.2016.05.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The diagnosis of progressive supranuclear palsy is often challenging early in the course of the disease, when clinical signs of the condition may be less apparent and patients do not clearly meet diagnostic criteria. In this study, we examine a potential radiographic marker in progressive supranuclear palsy, and assess the timing of its presence in relation to diagnosis. Methods: A retrospective review of patients fulfilling clinical research criteria for multiple system atrophy, Parkinson's disease, and progressive supranuclear palsy (total n = 75) was performed. Midbrain and pontine diameters, and the midbrain to pons ratio were calculated by a neuroradiologist blinded to the clinical diagnosis. The timing of the presence of a midbrain to pons ratio of less than or equal to 0.52 was assessed in the progressive supranuclear palsy group in reference to the time of diagnosis. Results: The midbrain to pons ratio was significantly reduced in the progressive supranuclear palsy cohort (p < 0.0001), and a midbrain to pons ratio of less than or equal to 0.52 was 100% specific for progressive supranuclear palsy. This radiologic sign predated the clinical diagnosis of progressive supranuclear palsy by a mean of 15 months (range 1-47 months) in 14 of 17 (82%) of patients in whom it was found. Conclusions: The midbrain to pons ratio is an easily applied and highly specific tool in the diagnosis of progressive supranuclear palsy, and is frequently present before the diagnosis is made. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:107 / 111
页数:5
相关论文
共 50 条
  • [41] Progressive supranuclear palsy: Neuropathology, clinical presentation, diagnostic challenges, management, and emerging therapies
    DeRosier, Frederick
    Hibbs, Cody
    Alessi, Kaitlyn
    Padda, Inderbir
    Rodriguez, Jeanette
    Pradeep, Swati
    Parmar, Mayur S.
    DM DISEASE-A-MONTH, 2024, 70 (08):
  • [42] Clinical Features Observed in General Practice Associated With the Subsequent Diagnosis of Progressive Supranuclear Palsy
    Kwasny, Mary J.
    Oleske, Denise M.
    Zamudio, Jorge
    Diegidio, Robert
    Hoeglinger, Gunter U.
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [43] Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy
    Josephs, Keith A.
    Duffy, Joseph R.
    CURRENT OPINION IN NEUROLOGY, 2008, 21 (06) : 688 - 692
  • [44] Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy
    Morris, HR
    Gibb, G
    Katzenschlager, R
    Wood, NW
    Hanger, DP
    Strand, C
    Lashley, T
    Daniel, SE
    Lees, AJ
    Anderton, BH
    Revesz, T
    BRAIN, 2002, 125 : 969 - 975
  • [45] Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants
    Whitwell, Jennifer L.
    Tosakulwong, Nirubol
    Botha, Hugo
    Ali, Farwa
    Clark, Heather M.
    Duffy, Joseph R.
    Utianski, Rene L.
    Stevens, Chase A.
    Weigand, Stephen D.
    Schwarz, Christopher G.
    Senjem, Matthew L.
    Jack, Clifford R.
    Lowe, Val J.
    Ahlskog, J. Eric
    Dickson, Dennis W.
    Josephs, Keith A.
    NEUROIMAGE-CLINICAL, 2020, 25
  • [46] Clinical presentation and management of multiple system atrophy and progressive supranuclear palsy
    Geser, F
    Wenning, GK
    PSYCHOPHARMAKOTHERAPIE, 2005, 12 (02): : 40 - +
  • [47] Clinical correlations of microstructural changes in progressive supranuclear palsy
    Tessitore, Alessandro
    Giordano, Alfonso
    Caiazzo, Giuseppina
    Corbo, Daniele
    De Micco, Rosa
    Russo, Antonio
    Liguori, Sara
    Cirillo, Mario
    Esposito, Fabrizio
    Tedeschi, Gioacchino
    NEUROBIOLOGY OF AGING, 2014, 35 (10) : 2404 - 2410
  • [48] Progressive supranuclear palsy. Clinical and neuroimaging features
    Carrilho, PEM
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2001, 59 (3A) : 649 - 649
  • [49] Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy
    Cordato, NJ
    Duggins, AJ
    Halliday, GM
    Morris, JGL
    Pantelis, C
    BRAIN, 2005, 128 : 1259 - 1266
  • [50] The midbrain to pons ratio A simple and specific MRI sign of progressive supranuclear palsy
    Massey, Luke A.
    Jaeger, Hans R.
    Paviour, Dominic C.
    O'Sullivan, Sean S.
    Ling, Helen
    Williams, David R.
    Kallis, Constantinos
    Holton, Janice
    Revesz, Tamas
    Burn, David J.
    Yousry, Tarek
    Lees, Andrew J.
    Fox, Nick C.
    Micallef, Caroline
    NEUROLOGY, 2013, 80 (20) : 1856 - 1861